HER2 extracellular domain
US6333169A · kind A · utility
79Cited by
10References
16Claims
0Family size
Inventors
Key dates
| Filing date | Apr 14, 1995 |
| Grant date | Dec 25, 2001 |
| Priority date | — |
| Expiry date | Apr 14, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An extracellular portion of the HER2 molecule, essentially free of transmembrane and cytoplasmic portions, which is antigenic in animals. Isolated DNA encoding the extracellular portion; an expression vector containing the isolated DNA; and a cell containing the expression vector. A process for producing the extracellular domain. A vaccine containing the extracellular domain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.